Market Blog

Sentiments dictate BioMarin and

BMRN– BioMarin Pharmaceutical Inc evelops and commercializes pharmaceuticals for various diseases and medical conditions. BMRN– BioMarin Pharmaceutical Inc Fundamentals Previously closed at 89.65 Day's high 91.26 Day's low 88.94 P/E ratio NA EPS -1.18   Analysts opinion BioMarin is a specialist in rare-disease specialist. The controversial drug Kyndrisa, which intended to treat Duchenne muscular dystrophy was rejected by the Committee for Medical Products for Human Use (CHMP). Analyst confidence meter,